Islamabad: Restrictions have been imposed on the sale and use of injections used for pain relief, which could prove fatal if used. According to details, the Drug Regulatory Authority declared one batch of painkiller medicine substandard and issued a product recall for Artecid injection.
The Drug Regulatory Authority declared one batch of Artecid injection 75 milli grams non-compliant and recalled the product while stating that Artecid injection 75 mg Bio Labs is prepared in Islamabad.
Central Drug Lab Karachi declared Artecid injection batch 23A018 non-compliant, stating that the sample did not meet the standard of the quality test.
Artecid injection is a painkiller prepared from diclofenac sodium, and the sample contained contamination of ethylene glycol.
The recall stated that the Artecid sample contained 19.66% ethylene glycol, which is a poisonous substance with harmful effects on the central nervous system, heart, and kidneys.
The use of ethylene glycol can be fatal, with no evidence of absorption in the human body, and there is no data on its toxic effects in humans or animals.
The Drug Regulatory Authority stated that the use of substandard Artecid injection could result in adverse reactions, and the company should stop supplying the affected batch of Artecid injection, recall it from the market.
Pharmacies should immediately stop selling the affected batch of Artecid injection, and chemists should return the affected batch of Artecid injection, while doctors and patients should not use the affected batch of Artisid injection and report adverse effects to the authority.
